ProterixBio Names Dr. Fernando Martinez of Weill Cornell to Its Scientific Advisory Board


by |

Share this article:

Share article via email
IPF and fibrotic diseases

Dr. Fernando Martinez, a clinical specialist in lung diseases such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), is the newest member of the scientific and medical advisory board of ProterixBio, the company announced. His appointment as scientific and medical advisor reflects the company’s focus on solutions to improve care for major lung diseases.

ProterixBio is developing disease management platforms that evaluate patient outcomes, starting with pulmonary diseases. A key part of these are biological measurement tools that aid in  patient assessment and treatment decisions, with an initial focus on IPF, COPD, and cystic fibrosis (CF).

“ProterixBio is thrilled to have Dr. Martinez join our scientific and medical advisory board,” said Grace E. Colón, PhD, President and Chief Executive Officer of ProterixBio, in a press release. “His decades of leadership in the field and passion for our vision and mission will help us at a critical time as we soon reach feasibility stage for our first product for COPD disease management.”

“I am honored and excited to advise ProterixBio on critical diseases such as COPD and idiopathic pulmonary fibrosis,” said Dr. Martinez. “I look forward to collaborating with the company on clinical studies designed to better assess their disease. A better evaluation of patients via molecular and traditional methods will ultimately benefit pulmonary patients through better management of their disease, fostering personalized care and, hopefully, improving outcomes and relieving burden on our patients.”

Dr. Martinez is the executive vice chair of medicine at Weill Cornell Medical College, and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Since 2002, he has been listed every year in the publication, “Best Doctors of America.” He is a top translational investigator in chronic lung diseases, with seminal studies in the phenotypic and functional classification, and clinical interventions in COPD and interstitial lung disease.

Dr. Martinez received his bachelor of science and doctor of medicine degrees at the University of Florida, and completed his internal medicine residency at Beth Israel Hospital/Harvard Medical School in 1986. He pursued a Pulmonary and Critical Care Medicine Fellowship at Boston University before joining the University of Michigan Medical Center as an assistant professor of medicine in 1991, where he was later named a professor of medicine.

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums